You Decide

"RFID Chip to Detect Swine Flu Virus?

Source Steve Quayle News Alerts

August 25, 2009
RFID Weblog

"I have seen swine flu or H1N1 virus snuff life out of a young person known to me and he was just one of the several hundred persons in whose case the virus was detected at a late stage making it nearly impossible for any sort of recovery.

Realizing the seriousness of the situation, VeriChip, the only company in the world which has been federally approved for producing radio microchips for implanting in humans has now started working towards creating an RFID chip which can detect the presence of deadly swine flu and other viruses which are being deemed as bio threat.

VeriChip is working along with Receptors to create an implant which would give a warning if the host is infected with H5N1 bird flu virus, H1N1 swine flu virus or other pandemic agents which are termed as bio threat.

I hope it happens soon as the virus has already spread its fangs worldwide claiming as many lives as it could and still continues to spread terror.

http://www.rfid-weblog.com/50226711/rfid_chip_to_detect_swine_flu_virus.php


Comments from Listener

September 1, 2009
John H.

Steve,

Do you think they're lining up these RFID 'swine flu' / 'any flu' chips to work in conjunction with the DNA vaccines I discussed with you?

I can assure you. THEY are lining this up.

See for yourself below.

Realizing the seriousness of the situation, VeriChip, the only company in the world which has been federally approved for producing radio microchips for implanting in humans has now started working towards creating an RFID chip which can detect the presence of deadly swine flu and other viruses which are being deemed as bio threat.

VeriChip is working along with Receptors to create an implant which would give a warning if the host is infected with H5N1 bird flu virus, H1N1 swine flu virus or other pandemic agents which are termed as bio threat.

I hope it happens soon as the virus has already spread its fangs worldwide claiming as many lives as it could and still continues to spread terror.

...and

Avian flu chips go commercial  
http://www.eetimes.com/showArticle.jhtml?articleID=196801208


EE Times
(01/04/2007 5:23 PM EST)

PORTLAND, Ore. — Avian flu chips validated by the U.S. Centers for Disease Control and Prevention (CDC) could soon be showing up at U.S. medical clinics.

The "MChip," a microarray which can quickly identify avian flu, will be used to monitor a possible pandemic. It could also be used to streamline clinical laboratory testing. Quidel Corp. (San Diego) holds an exclusive license to manufacture and distribute avian influenza test kits using the patented MChip.

"Quidel's test kits will use a new and improved version of our original flu chip, which we call the MChip," said Kathy Rowlen, project leader for a University of Colorado research team. "The MChip uses very clever bioinformatics to require only a single gene, making it is a substantial improvement over our first version of the chip."

University of Colorado professor Kathy Rowlen shows its flu chip jointly patented with the CDC.
Flu chips use microarrays containing thousands of DNA protein sequences, each with a fluorescent marker that glows when a match is found. By exposing the entire chip to a patient sample, the microarray can simultaneously test for matches with all its sequences, reducing testing time from days to minutes. The National Instittutes of Health is making a conventional microarray for influenza testing under its Consortium for Functional Glycomics project.

Developers claim the MChip is an improvement over traditional influenza microarrays by requiring a match with only a single avian flu gene. Rival mircoarrays require matching sequences from all three influenza genes—hemagglutinin, neuraminidase and the matrix.

The MChip requires only matching sequences from the matrix gene, which mutates more slowly than hemagglutinin and neuraminidase genes, thereby improving reliability as well as shortening testing time.

Conventional influenza microarrays "require literally thousands of sequences, making them comparitively expensive," said Rowlen. "But the MChip is substantially smaller than a conventional microarray since it only needs 15 sequences from a single gene to reliably identify avian flu."

The MChip was jointly developed by the University of Colorado and the CDC, which are co-owners of the original patent. The CDC validated the MChip by testing it with samples of avian flu (called H5N1) collected from both humans and animals over three years. The CDC said the MChip achieved 100 percent specificity, with no reported false positives and a 97 percent sensitivity in identifying avian flu.

Quidel will use its exclusive license to integrate the MChip into its existing line of immunoassay tests for flu, which are used both in clinical laboratories and at doctors' offices.

When I said I attended a COR symposium and THIS is what they discussed in 88, I wasn't fooling around.

John H."

http://www.stevequayle.com/News.alert/09_Disease/090901.chip-flu.html